Researchers from the National Centre for Neuroimmunology and Emerging Diseases (NCNED) have discovered a cell receptor which could be a key contributing factor to Chronic Fatigue Syndrome (CFS).
CFS is a debilitating disorder characterised by extreme fatigue or tiredness that doesn’t go away with rest. It can also be referred to as Myalgic Encephalomyelitis (ME). Around 400,000 Australians are believed to be affected by CFS, many of whom are house bound or bed bound.
Lead researchers, Professor Sonya Marshall-Gradisnik and Professor Don Staines discussed the challenges with CFS diagnosis, clinical presentation, and treatments. They shared their recent research findings, such as immunological, cell signalling and genetic features in CFS/MEl patients.